Key result
Targeted transfusion and gamma globulin resolve repeated coagulation disorders in neonatal intrauterine CVB1 infection.
Why the study?
Neonatal coxsackievirus B1 infection can cause severe clinical manifestations including repeated coagulation disorder, but its clinical course and monitoring remain unclear.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Neonatal coxsackievirus B1 infection can present with repeated coagulation disorders, requiring careful monitoring through the second viremia phase.
To the Editors: Enterovirus is the most common pathogenic virus in the neonatal period.1 Unlike older children, neonatal enterovirus infection is often severe, and its clinical manifestations are difficult to distinguish from bacterial sepsis. In severe cases, necrotic hepatitis, meningitis and myocarditis can occur, with rapid development and high mortality.2 Coxsackievirus is a single-strand RNA virus belonging to the family Parvoviridae, the most common enterovirus infection in neonates. Neonatal coxsackievirus infection can be transmitted vertically in utero or horizontally after birth, but the symptoms of intrauterine infection are more serious than postnatal infection.3 This report describes a rare case of a neonate diagnosed with repeated coagulation disorder caused by intrauterine coxsackievirus B1 (CVB1) infection. A 5-day-old male neonate presented with scattered ecchymosis and petechiae all over the body as the primary clinical manifestation. His mother had a history of fevers 1 week before delivery. After birth, the placenta was examined by pathologic examination, and 2 g of the placenta was frozen at −20 ℃ for further use. Investigations revealed a platelet count of 7 × 109/L, prothrombin time (PT) >100 s, and activated partial thromboplastin time (APTT) >150 s. Infection indicators such as blood culture, leucocyte, C-reactive protein and procalcitonin were normal. Placental pathology revealed placental chorioamnionitis. RT-PCR detection of Coxsackievirus B nucleic acid in placental tissue was positive. Metagenomic next-generation sequencing (mNGS) results in peripheral blood were CVB1, and no other pathogens were detected. He was diagnosed with coagulopathy associated with CVB1 based on the clinical and mNGS findings. After admission, plasma, prothrombin complex, platelet and gamma globulin were infused. Four days later, the patient’s coagulation function test and platelet count returned to normal. However, 2 days later, his PT and APTT were significantly abnormal again, and plasma and prothrombin complex continued to be infused. On the eight day of hospitalization, the patient’s condition gradually stabilized, and mNGS reexamination of peripheral blood did not show any pathogens. During hospitalization, the patient received gamma globulin 2 g/kg, plasma 20 mL/kg 4 times, prothrombin complex 20 U/kg 3 times, and platelet 20 mL/kg 2 times. The boy had no relapse at the 1-month follow-up after discharge. The laboratory data are summarized in Figure 1.FIGURE 1.: The changes of coagulation routine in the child during treatment.Bae et al4 reported a CVB1 infection in a newborn who developed myocarditis several days after the diagnosis of meningitis. The prominent clinical manifestation of this neonate was repeated coagulation disorder after CVB1 disease, which indicated that CVB1 could lead to symptoms through the first and second viremia. In treating neonatal CVB1 infection, attention should be paid to the clinical condition of children until the end of the second viremia. However, the difficulty is that the course of neonatal coxsackievirus infection is relatively long, and some studies have found that coxsackievirus viremia can persist in the body for up to 6 weeks.5 In addition, the severity of the disease may be related to viral load and high inflammatory response. Whether the mNGS method can be used to monitor coxsackievirus load to determine the course of illness needs further study.
No takes yet. Share an insight, caveat, or question.
Junjie Ning (2022) conducted a case report in Coagulopathy associated with Coxsackievirus B1 (CVB1) infection (n=1). Intrauterine coxsackievirus B1 (CVB1) infection was evaluated on Resolution of coagulopathy. Intrauterine coxsackievirus B1 (CVB1) infection in a 5-day-old neonate caused repeated coagulation disorders that successfully resolved following targeted transfusion and gamma globulin therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: